Skip to main content
. 2016 Nov 15;16:467. doi: 10.1186/s12906-016-1429-x

Fig. 9.

Fig. 9

Effects of lead anti-inflammatory products on IL-6 release in LPS treated BV-2 and RAW 264.7 cells. The data represents IL-6 (as % LPS Control) and expressed as the Mean ± S.E.M., n = 3. Differences between activated cells ± natural compounds at sub-lethal dose were determined by a student’s T test (*) P < 0.001